U.S. Marine and Shipping Stock News

Caris Life Sciences has had a difficult year for shareholders, with the stock down 47.3% over the past 12 months, yet its valuation checks still lean toward the shares looking cheap rather than expensive. With fresh product news in precision oncology and multi cancer screening, the question is whether the market is being too cautious or the valuation score is missing important risks. Over the last year, Caris Life Sciences has declined 47.3%, which suggests sentiment around the stock has...

Coupang stock has fallen about 56% over the past five years, yet its current valuation checks lean cheap. This sets up a clear question for investors about whether the market is being too harsh or the risks are simply catching up with the share price. The share price decline of roughly 56% over five years suggests long term holders have faced heavy losses and the market has repeatedly reassessed what Coupang is worth. On the one hand, Coupang's push into new offerings and markets can support...

In July 2026, BlackSky Technology Inc. announced it had secured multiple U.S. R&D contracts to advance Gen-3 AI solutions for real-time, space-based tactical intelligence, surveillance and reconnaissance, including maturing automated target recognition within classified customer workflows. A distinctive aspect of these awards is BlackSky’s continued development of AI-enabled Battle Damage Detection analytics on its commercial Gen-3 platform, leveraging 35-centimeter resolution imagery to...

3M (NYSE:MMM) and Microsoft announced a partnership to deploy 3M's Expanded Beam Optical technology in Microsoft Azure data centers. The collaboration focuses on data center connectivity for AI workloads and broader enterprise digital transformation at 3M. The agreement includes joint innovation plans that may influence both companies' roles in cloud and AI supply chains. For investors watching how industrial companies plug into the AI and cloud build out, this move puts 3M directly inside...

Innodata's share price has climbed sharply over the past few years, yet its current checks lean toward the stock looking expensive rather than like an obvious bargain. After such a strong run, the tension for investors is between the powerful long term return profile and a low value score that points to limited margin of safety at today's levels. Over the last 5 years, Innodata has delivered a very large total return of about 8x, which sets a high bar for any further upside from...

Caesars Entertainment (CZR) has drawn fresh investor attention after unveiling Caesars Republic Lake Tahoe Hotel & Casino and completing a multi phase refresh of the former Harveys Lake Tahoe with updated rooms, gaming, dining and entertainment. See our latest analysis for Caesars Entertainment. Recent events, including the Lake Tahoe relaunch and a board resignation announcement, come as Caesars Entertainment’s share price has a 90 day share price return of 9.88% and a year to date share...

BioLife Solutions has delivered a 51.1% return over the last three years, yet its valuation signals are split, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to upside while market multiples suggest the stock is priced on the rich side and the broader value checks lean expensive. Over the last three years, BioLife Solutions has returned 51.1%, which puts more scrutiny on whether the current share price still leaves room for attractive long term returns. Expectations...

In the last week, the United States market has stayed flat, yet it is up 19% over the past year with earnings forecasted to grow by 18% annually. In this context of steady growth and future potential, identifying small-cap stocks that are perceived as undervalued can offer intriguing opportunities for investors seeking to capitalize on insider actions across global markets.

Over the last 7 days, the United States market has remained flat, yet it has experienced a notable rise of 19% over the past year. In this environment where earnings are expected to grow by 18% annually in the coming years, identifying stocks that are estimated to be below their fair market value can offer potential opportunities for investors seeking to capitalize on future growth.

The United States market remained flat over the last week but has seen a 19% increase over the past year, with earnings projected to grow by 18% annually. In this environment, growth companies with significant insider ownership can be appealing as they often indicate strong confidence from those closest to the business, potentially aligning well with future market expectations.

The market remained flat over the last week but is up 19% over the past year, with earnings forecast to grow by 18% annually. For those looking to invest in smaller or newer companies, penny stocks can still offer surprising value. In this article, we explore several penny stocks that demonstrate financial strength and potential for long-term growth.

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, Contineum...

Fulton Financial stock has delivered a 110.0% return over the past three years, yet its intrinsic value estimate from the Excess Returns model still suggests the shares trade at a sizable discount, while broader valuation checks point to a more mixed picture. A 110.0% three year return puts Fulton Financial among the stronger performers in regional banking, which raises the bar for what counts as good value today. The completed merger of Blue Foundry Bank into Fulton Bank, N.A. can support...

Cohu stock has surged over the past year, yet the valuation signals are mixed, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium to the current market price, while market based multiples suggest the shares are closer to fairly valued. Over the last 1 year, Cohu has returned 157.2%, which puts the recent pullback into context as a move after a very strong run. Fresh analyst enthusiasm around Cohu's role in AI driven semiconductor testing may support higher...

We wouldn't blame The Kroger Co. ( NYSE:KR ) shareholders if they were a little worried about the fact that Yael...

SpaceX’s post IPO slide, from a market value above $2.6 trillion to about $1.72 trillion within days, has sent a clear message to anyone watching new listings closely. When a flagship space stock stumbles after listing and short sellers walk away with an estimated $3.9 billion, it can rattle confidence well beyond one ticker. This article looks at three stocks exposed to the same news shock, each facing its own version of post debut volatility risk. You will see where the pressure points are...

Middle East oil routes are being redrawn as the Strait of Hormuz closure disrupts Iraq’s exports and pushes governments and energy majors to rethink how crude leaves the region. For investors, this shift is less about short term headlines and more about which stocks are directly exposed to the surge in pipeline construction, oilfield services and security heavy infrastructure projects tied to new export corridors through Iraq and Syria. This article walks through 3 stocks linked to that news,...

Keros Therapeutics, Inc.'s (NASDAQ:KROS) stock price has dropped 12% in the previous week, but insiders who sold...

FormFactor stock has delivered a very strong 3 year return and is still up sharply over the past year, yet the valuation checks currently lean expensive rather than pointing to an obvious bargain. FormFactor has returned 207.5% over the past 3 years, which puts extra focus on whether today’s price still offers a comfortable margin for error. AI driven demand for high bandwidth memory and related chip testing can support optimistic expectations, but recent concerns about overvaluation and...

Timken stock has almost doubled over the past five years, and at around US$137.69 per share the Discounted Cash Flow (DCF) intrinsic value estimate still points to roughly 20.3% upside, even though the broader valuation checks only give the company a low score. Timken has returned about 95.9% over five years, which puts today’s valuation debate in the context of a stock that has already rewarded long term holders. The newly secured US$1.2b unsecured revolving credit facility can support...

Delta Air Lines, Inc.'s ( NYSE:DAL ) recent weak earnings report didn't cause a big stock movement. However, we believe...

We wouldn't blame Covista Inc. ( NYSE:CVSA ) shareholders if they were a little worried about the fact that Stephen...